Strides Pharma Science Publishes BRSR 2025-26 Highlighting Global Reach and Commitment to ESG

Strides Pharma Science Publishes BRSR 2025-26 Highlighting Global Reach and Commitment to ESG​

Strides Pharma Science Limited has released its Business Responsibility & Sustainability Report (BRSR) for the Financial Year (FY) 2025-26. The report outlines the company’s extensive global operations, operational efficiency metrics across environmental parameters, and commitment to ethical governance as a leading pharmaceutical manufacturer.

The listed entity maintains significant international presence, serving markets in 106 countries. Its business activities focus entirely on chemical and chemical products manufacturing, generating 100% of its turnover through this primary activity. Strides reports that exports constitute 90.66% of the total turnover on a standalone basis.

Operational Footprint and Human Capital​

The company's operational landscape includes five plants and/or R&D centers across Bangalore, Puducherry, and Alathur in India, alongside two registered and one corporate office domestically. Globally, Strides operates eleven facilities spanning various international locations, including the USA, Italy, Kenya, and multiple offices located in countries such as the UK, Singapore, Switzerland, and Canada.

The company maintains a substantial workforce:

• Employees: As of FY 2025-26, total employees stand at 2,810 (73% male, 27% female). Among permanent staff, there are 2,549 employees, including 623 females, representing a 24% representation rate.
• Workers: Total workers amount to 2,584, with a 71% male and 29% female distribution.

Governance indicators show that the Board of Directors has two members who are female, comprising 25% of the board. Key Management Personnel (KMP) also include one woman, contributing 20% to KMP representation.

Environmental Stewardship and Resource Efficiency​

The BRSR details Strides’ efforts toward resource efficiency, emphasizing both energy conservation and sustainable waste management across its operations.

Resource Intensity:

• Energy intensity per rupee of turnover stands at 12.86 KJ/I Lakhs, showing improvement from the previous year's figure of 10.66.
• Water consumption intensity is reported at 0.87 KL/K. Lakh, which aligns with its previous reporting period’s intensity of 0.88.

Climate and Energy: The company actively pursues carbon footprint reduction initiatives. Strides installed 698,358 KW solar power plants and utilizes rooftop solar power panels, contributing to approximately 45% of total power consumption across all sites from renewable sources.

• Total Scope 1 Emissions for FY 2025-26 were recorded at 6,542.27 Metric tonnes of CO2 equivalent.
• Total Scope 2 Emissions stood at 18,837.76 Metric tonnes of CO2 equivalent.

Waste Management: The total waste generated was reported at 1,910.28 MT for FY 2025-26, up from 1,516.67 MT in the preceding year. A significant commitment to resource management is reflected in the recovery operations, totaling 1,207.40 MT across recycling and other recovery processes.

Workplace Health and Ethical Commitments​

The report details comprehensive measures to ensure employee wellbeing, safe working conditions, and fair engagement with stakeholders:

Employee Wellbeing: The cost incurred on well-being measures across all employees (permanent and non-permanent) amounted to 0.44% of total revenue for FY 2025-26.

• Safety Performance: The Lost Time Injury Frequency Rate (LTIFR) for employees was reported at 0.11 per one million person hours worked, with zero fatalities reported in both reporting years.
• Human Rights Focus: A dedicated Human Rights Policy has been established to ensure all business dealings respect fundamental human rights and discourage involvement in violations.

Fairness and Sourcing: Strides maintains a Vendor Code of Conduct requiring adherence to principles like Environmental Sustainability and Health and Safety by all suppliers. In terms of sourcing, 14.43% of input material was sourced from Micro Small Enterprises (MSMEs)/Small producers, while 80.40% came directly from within India.

Consumer Grievances: The company’s complaint management system is designed as a risk-based approach. In FY 2025-26, the entity received 426 customer complaints, of which 58 are pending investigation, while the previous year saw 368 complaints filed with all being closed.

Organizational Governance Details​

Key metrics related to business openness and compliance include:

• Accounts Payable: The number of days of accounts payables stands at 115 for FY 2025-26, down from 123 in FY 2024-25.
• Related Party Transactions (RPTs): RPTs accounted for 22.90% of purchases and 86.40% of sales, with Investments made in related parties at 99.58%.

The BRSR underscores the company’s commitment to responsible growth by ensuring continuous improvements in resource efficiency while maintaining a high standard of ethical oversight across its diverse global operations.

STAR Stock Price Movement​

Shares of Strides Pharma Science Limited slipped slightly in post-market trading today, settling at ₹1052.8 after shedding ₹6.70 from the previous close. The stock traded throughout the session within a band defined by a high of ₹1063.8 and a low of ₹1039.9, with 88,314 shares transacting today.